The fetal monitoring market is expanding with the latest innovative technologies, backed by escalating research and product launches. Fetal monitoring technologies are now being streamlined to provide greater assistance in utero fetal surgeries, consisting of challenging physical fetal access and technological complications.     Fetal cardiac assessments have also witnessed progress...

The fetal monitoring market is expanding with the latest innovative technologies, backed by escalating research and product launches. Fetal monitoring technologies are now being streamlined to provide greater assistance in utero fetal surgeries, consisting of challenging physical fetal access and technological complications.     Fetal cardiac assessments have also witnessed progress...

The growth in this market is driven by factors such as the rising focus on minimizing medical errors, government initiatives for HCIT adoption, and disparity and fragmentation in the terminology content of healthcare organizations.    On the basis of application, the data aggregation segment accounted for the largest share of the medical terminology software market in 2018. The large...

The Healthcare Facility Management Market-US Forecast is growing with the increasing investments into the healthcare infrastructure and healthcare facility construction projects in the US, the rising geriatric population base, increasing patient volume along with the rising prevalence of chronic diseases and infections (COVID-19), and their increasing healthcare expenditure.    The...

The growth of this market is majorly driven by the increasing research in the life sciences industry and the growing need to identify antigens associated with autoimmune diseases (through antigen-antibody interaction to understand disease mechanisms and develop relevant drugs targeting these diseases).    The kits segment is projected to grow at the highest CAGR between 2018 and 2024....

Currently, a number of vaccines or antiviral drugs for COVID-19 have been approved or are under development, and patients are currently treated symptomatically. For both vaccines and therapeutics, the antibodies produced are tested for their functional efficacy to neutralize the target virus.    The cell-based assays market is projected to reach USD 22.0 billion by 2025, at a CAGR of...

The rising prevalence of cancer, initiatives undertaken by government and global health organizations, and the increasing preference for minimally invasive procedures are the major factors driving the growth of the aspiration and biopsy needle market.    The COVID-19 pandemic has resulted in significant reductions in cancer screening, cancer management visits, and cancer biopsy...

Growth in cell & gene therapy manufacturing services market is primarily driven by the high incidence of cancer and other target diseases, increasing investments in pharmaceutical R&D, investments in advanced technologies by CDMOs, and increasing partnerships & agreements between pharmaceutical companies and CDMOs.    Most pharmaceutical companies continue to invest...

The increased pressure due to the growing rate of hospitalization of COVID-19 patients had led to the re-profiling of many hospitals and departments for treating patients with COVID-19. Consequently, many elective surgeries were canceled or postponed worldwide to reserve or redirect the available limited capacities and resources (like hospital beds and patient care professionals) toward...

The increasing incidences of sports injuries, continuous influx of new products & treatment modalities, developments in the field of regenerative medicine, rising demand for minimally invasive surgeries.       Globally, the incidence of sports injuries has increased over the last few years, primarily due to the growing participation in sports as well as active...